MARCHESINI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 431
EU - Europa 280
AS - Asia 173
OC - Oceania 1
Totale 885
Nazione #
US - Stati Uniti d'America 414
IE - Irlanda 88
IT - Italia 69
HK - Hong Kong 54
SG - Singapore 51
VN - Vietnam 42
UA - Ucraina 32
CN - Cina 18
FI - Finlandia 18
CA - Canada 15
DE - Germania 15
RO - Romania 15
RU - Federazione Russa 13
SE - Svezia 12
CZ - Repubblica Ceca 5
AT - Austria 3
GB - Regno Unito 3
TR - Turchia 3
FR - Francia 2
KR - Corea 2
NL - Olanda 2
AU - Australia 1
CH - Svizzera 1
GL - Groenlandia 1
LB - Libano 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 885
Città #
Chandler 89
Dublin 88
Hong Kong 54
Dong Ket 42
Singapore 38
San Mateo 36
Perugia 29
Boardman 26
Jacksonville 21
Altamura 17
Medford 15
Ottawa 15
Princeton 15
Bucharest 14
Des Moines 12
Santa Clara 12
Lawrence 10
Andover 9
Beijing 9
Wilmington 9
Helsinki 8
Falls Church 7
Ashburn 6
Dearborn 5
Saint Petersburg 5
New York 4
Norwalk 4
Olomouc 4
Secaucus 4
Ancona 3
Buffalo 3
Izmir 3
Los Angeles 3
Munich 3
Redwood City 3
Ann Arbor 2
Pasadena 2
Redmond 2
San Paolo di Civitate 2
Seoul 2
Simi Valley 2
Amsterdam 1
Bragadiru 1
Chicago 1
Corciano 1
Den Haag 1
Elk Grove Village 1
Falkenstein 1
Figline Valdarno 1
Frankfurt Am Main 1
Hanover 1
Houston 1
Lausanne 1
Melbourne 1
Moscow 1
Narni 1
Newark 1
Nuuk 1
Saint Louis 1
San Diego 1
Temecula 1
Vienna 1
Totale 658
Nome #
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 91
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 70
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 65
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 63
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 61
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 56
The good use of plasma. A critical analysis of five international guidelines. 51
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 49
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 48
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 47
Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. 43
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 43
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 43
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 39
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 31
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 27
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population 27
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 26
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 22
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 21
Totale 923
Categoria #
all - tutte 4.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 6 4 5 15 8 9 1 1
2020/2021123 0 4 0 4 34 4 12 3 8 4 7 43
2021/2022155 1 25 1 2 10 2 5 41 3 10 21 34
2022/2023304 15 48 6 20 20 38 21 8 105 3 18 2
2023/2024187 12 18 14 4 3 4 48 1 12 8 27 36
2024/202547 4 28 15 0 0 0 0 0 0 0 0 0
Totale 923